secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2026-08-04T01:12:26+00:00
Accession:  0001213900-26-084846
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma postpones BioKey share distribution from August 3, 2026
----------------------------------------------------------------------

- Distribution of BioKey ordinary shares postponed to complete administrative, regulatory, and tax-related matters.
- Record date and distribution ratio of 0.169464 BioKey shares per ABVC share remain unchanged.
- Ex-dividend date will be revised; new distribution date to be announced after matters are finalized.
- Company coordinating with Nasdaq, DTC, and transfer agent on revised distribution mechanics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390026084846/0001213900-26-084846-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390026084846/ea0300449-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-084846

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer